Lastly, ERα degraders with tubulin inhibitory activity demonstrate dual functionality by degrading ERα while inhibiting tubulin polymerization, effectively disrupting both estrogen signaling and tumor cell cycle progression. The gene discussed is ESR1; the disease is neoplasm.